Patent classifications
C07C211/28
IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
A fragrance precursor of 3-(4-isobutyl-2-methyl phenyl)propanal, comprising at least an enamine and/or an aminal as reaction product of 3-(4-isobutyl-2-methylphenyl)propanal (compound according to formula (I)) and a primary and/or secondary amine
##STR00001##
useful as a perfume ingredient.
IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS
A fragrance precursor of 3-(4-isobutyl-2-methyl phenyl)propanal, comprising at least an enamine and/or an aminal as reaction product of 3-(4-isobutyl-2-methylphenyl)propanal (compound according to formula (I)) and a primary and/or secondary amine
##STR00001##
useful as a perfume ingredient.
Cross-linked plastic material with an intrinsic antimicrobial effect based on unsaturated polyesters
The present invention relates to a radically curable chemical composition in the form of a resin for the production of materials with an intrinsically antimicrobial effect, as well as a process for the production of such resins and materials, as well as the use of an amino-functionalized styrene derivative as reactive diluents. The cross-linked plastic formed upon curing has an intrinsically antimicrobial effect without the use of additional biocides.
Cross-linked plastic material with an intrinsic antimicrobial effect based on unsaturated polyesters
The present invention relates to a radically curable chemical composition in the form of a resin for the production of materials with an intrinsically antimicrobial effect, as well as a process for the production of such resins and materials, as well as the use of an amino-functionalized styrene derivative as reactive diluents. The cross-linked plastic formed upon curing has an intrinsically antimicrobial effect without the use of additional biocides.
Synthesis of novel ionic liquids from lignin-derived compounds
Methods and compositions are provided for synthesizing ionic liquids from lignin derived compounds comprising: contacting a starting material comprising lignin with a depolymerization agent to depolymerize the lignin and form a mixture of aldehyde containing compounds; contacting the mixture of aldehyde containing compounds with an amine under conditions suitable to convert the mixture of aldehyde containing compounds to a mixture of amine containing compounds; and contacting the mixture of amine containing compounds with an acid under conditions suitable to form an ammonium salt, thereby preparing the ionic liquid.
Synthesis of novel ionic liquids from lignin-derived compounds
Methods and compositions are provided for synthesizing ionic liquids from lignin derived compounds comprising: contacting a starting material comprising lignin with a depolymerization agent to depolymerize the lignin and form a mixture of aldehyde containing compounds; contacting the mixture of aldehyde containing compounds with an amine under conditions suitable to convert the mixture of aldehyde containing compounds to a mixture of amine containing compounds; and contacting the mixture of amine containing compounds with an acid under conditions suitable to form an ammonium salt, thereby preparing the ionic liquid.
RAPID SYNTHESIS METHOD FOR BIOMASS-BASED AMINE
A rapid synthesis method for a biomass-based amine, including: using formamide as an amine source, formic acid as a hydrogen source, and biomass aldehyde or ketone as a raw material, conduct rapid heating promoting direct addition of formamide and aldehyde or ketone compound through microwave-assisted heating and without a solvent and catalyst, and carrying out formic acid reduction preparing and obtaining a corresponding formamide derivative; selectively converting the formamide derivative under the action of a base into a corresponding primary amine through alcoholysis. The microwave-assisted heating reaction system has a significantly higher catalytic efficiency than a corresponding oil bath system, greatly shortens a reaction time, and significantly improves selectivity, where a conversion rate of a biomass aldehyde or ketone compound may reach at least 99%, and a formamide derivative yield may reach 85-99%; the formamide derivative is synthesized to a primary amine through alcoholysis, where a yield may reach 92-99%.
RAPID SYNTHESIS METHOD FOR BIOMASS-BASED AMINE
A rapid synthesis method for a biomass-based amine, including: using formamide as an amine source, formic acid as a hydrogen source, and biomass aldehyde or ketone as a raw material, conduct rapid heating promoting direct addition of formamide and aldehyde or ketone compound through microwave-assisted heating and without a solvent and catalyst, and carrying out formic acid reduction preparing and obtaining a corresponding formamide derivative; selectively converting the formamide derivative under the action of a base into a corresponding primary amine through alcoholysis. The microwave-assisted heating reaction system has a significantly higher catalytic efficiency than a corresponding oil bath system, greatly shortens a reaction time, and significantly improves selectivity, where a conversion rate of a biomass aldehyde or ketone compound may reach at least 99%, and a formamide derivative yield may reach 85-99%; the formamide derivative is synthesized to a primary amine through alcoholysis, where a yield may reach 92-99%.
Small Molecule Drugs and Related Methods for Treatment of Diseases Related to Abeta42 Oligomer Formation
The present invention provides small molecule drugs and pharmaceutical compositions for the treatment and prevention of diseases related to the formation of Aβ42 oligomers in a subject. It further provides a method of reducing formation of or disrupting Aβ42 oligomers in a subject, the method comprising the step of administering to the subject in need thereof a therapeutically effective amount of a pharmaceutical composition.
Small Molecule Drugs and Related Methods for Treatment of Diseases Related to Abeta42 Oligomer Formation
The present invention provides small molecule drugs and pharmaceutical compositions for the treatment and prevention of diseases related to the formation of Aβ42 oligomers in a subject. It further provides a method of reducing formation of or disrupting Aβ42 oligomers in a subject, the method comprising the step of administering to the subject in need thereof a therapeutically effective amount of a pharmaceutical composition.